comparison of immunoperoxidase staining with indirect immunofluorescence, elisa, and western blotting assays for detecting anti-htlv-i antibodies in systemic lupus erythematosus.

NLM AIDSLINE Comparison of immunoperoxidase staining with indirect immunofluorescence, ELISA, and Western blotting assays for detecting anti-HTLV-I antibodies in systemic lupus erythematosus. Yamaguchi K; Matutes E; Kiyokawa T; Nishimura Y; Ishii T; Takatsuki K;
June 30, 1988

J Clin Pathol. 1988 Jan;41(1):57-61. Unique Identifier : AIDSLINE Serum antibodies against human T cell leukaemia virus type I (HTLV-I) were investigated in 12 patients by four methods: indirect immunoperoxidase staining, indirect immunofluorescence, enzyme linked immunosorbent assay (ELISA), and strip radioimmunoassay based on the Western blotting assay. Seven patients had systemic lupus erythematosus (SLE) and five various autoimmune diseases with one or more circulating autoantibodies. Serum samples from three patients were found to be HTLV-I-positive by the ELISA assay and sera from five patients showed a non-specific reaction by indirect immunofluorescence. These sera were negative when tested by indirect immunoperoxidase staining and Western blotting assay. All four methods gave positive results when tested with samples from 19 HTLV-I carriers and 16 patients with adult T cell leukaemia. Indirect immunoperoxidase staining and Western blotting assay are probably useful and more specific assays for the detection of anti-HTLV-I antibodies in samples from patients with autoimmune diseases. Adult Aged Antibodies, Viral/ANALYSIS Autoimmune Diseases/IMMUNOLOGY Comparative Study Enzyme-Linked Immunosorbent Assay Female Fluorescent Antibody Technique Human HTLV-BLV Viruses/IMMUNOLOGY Immunoenzyme Techniques Lupus Erythematosus, Systemic/*IMMUNOLOGY Middle Age Radioimmunoassay Support, Non-U.S. Gov't JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 HIV messages should include MSM Stock-outs must be top of agenda TEXAS: Free HIV Testing CALIFORNIA: Entertainment AIDS Alliance (EAA) Presents 11th Annual Wine and Wisdom Fundraiser NORTH CAROLINA: ALFA Offers Free Community Health Educator Training in Hickory CALIFORNIA: Over Half of People Living with AIDS in San Francisco Are Aged 50 or Older THAILAND; UNITED STATES: HIV Drug Can Also Protect Injection Drug Users INDONESIA: Growing HIV/AIDS Awareness in Indonesia's Papua Region UNITED STATES: Many Young Americans Unaware They're Infected with HIV Board to Vote on Condoms in Boston Schools Detecting Disease with a Smartphone Accessory UKRAINE: Hepatitis C Most Often Detected in Potential Donors Blood Uganda: Wakiso Launches Anti HIV/AIDS Campaign GHANA: IOM Launches Mobile Initiative to Counter Tuberculosis in Western Ghana Nigeria lawmakers pass anti-gay marriage bill La lutte anti-sida de demain: pas de baguette magique mais un cocktail Russia has 'no anti-AIDS strategy': official India's Largest Generic Drugmaker Ranbaxy Pays $500 Million to Settle Systemic Generic Drug Manufacturing Fraud NIH Scientists Create New Tool for Identifying Powerful HIV Antibodies: Advance Could Speed HIV Vaccine Research Feuding antibodies blocked HIV vaccine
Information in this article was accurate in June 30, 1988. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.